ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a,...

by Tsutomu Takeuchi, Yoshiya Tanaka, Jay Erdman, Yuichiro Kaneko, Masako Saito, Chieri Higashitani, Ronald Smulders, Christopher Lademacher
Published 2020-10-01

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population

by Leticia Delgado-Herrera, Kathryn Lasch, Bernhardt Zeiher, Anthony J. Lembo, Douglas A. Drossman, Benjamin Banderas, Kathleen Rosa, Christopher Lademacher, Rob Arbuckle
Published 2017-09-01

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant re...

by Per Ljungman, Arancha Bermudez, Aaron C. Logan, Mohamed A. Kharfan-Dabaja, Patrice Chevallier, Rodrigo Martino, Gerald Wulf, Dominik Selleslag, Kazuhiko Kakihana, Amelia Langston, Dong-Gun Lee, Carlos Solano, Shinichiro Okamoto, Larry R. Smith, Michael Boeckh, John R. Wingard, Beth Cywin, Christine Fredericks, Christopher Lademacher, Xuegong Wang, James Young, Johan Maertens
Published 2021-03-01